Why the study?
The pathogenesis of renal injury in malignant hypertension remains incompletely understood beyond the recognized roles of high blood pressure and the renin-angiotensin-aldosterone system.
Population
Rat model of two-kidney, one-clip renovascular hypertension
Comparison
Malignant hypertension vs non-malignant hypertension vs normotensive sham-operated controls
Design
Preclinical transcriptomic study using RNA sequencing
Authors
Loading...
Hypothesis-generating for complement inhibition in malignant hypertensive kidney injury; prospective human studies needed before clinical consideration.
In a rat model of malignant hypertension, RNA sequencing revealed specific upregulation of inflammatory pathways, notably the complement cascades, suggesting a potential role for complement inhibitors in alleviating hypertension-induced kidney injury.
Menendez‐Castro et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: